Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018037

Expand all

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;75MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;75MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 006
Approval Date: Apr 13, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;150MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 007
Approval Date: Apr 13, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;224MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;224MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;150MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 008
Approval Date: Apr 13, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;300MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;224MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;224MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 005
Approval Date: Apr 13, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;300MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;300MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 009
Approval Date: Apr 13, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;75MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;75MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) (DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE)
5GM/100ML;150MG/100ML;200MG/100ML
Marketing Status: Prescription

Active Ingredient: DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Proprietary Name: DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K)
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5GM/100ML;150MG/100ML;200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018037
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information